• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人胚胎干细胞分化过程中心肌细胞的鉴定与筛选。

Identification and selection of cardiomyocytes during human embryonic stem cell differentiation.

作者信息

Huber Irit, Itzhaki Ilanit, Caspi Oren, Arbel Gil, Tzukerman Maty, Gepstein Amira, Habib Manhal, Yankelson Lior, Kehat Izhak, Gepstein Lior

机构信息

Sohnis Family Research Laboratory for the Regeneration of Functional Myocardium and the Rappaport Family Institute for Research in the Medical Sciences, The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

出版信息

FASEB J. 2007 Aug;21(10):2551-63. doi: 10.1096/fj.05-5711com. Epub 2007 Apr 13.

DOI:10.1096/fj.05-5711com
PMID:17435178
Abstract

Human embryonic stem cells (hESC) are pluripotent lines that can differentiate in vitro into cell derivatives of all three germ layers, including cardiomyocytes. Successful application of these unique cells in the areas of cardiovascular research and regenerative medicine has been hampered by difficulties in identifying and selecting specific cardiac progenitor cells from the mixed population of differentiating cells. We report the generation of stable transgenic hESC lines, using lentiviral vectors, and single-cell clones that express a reporter gene (eGFP) under the transcriptional control of a cardiac-specific promoter (the human myosin light chain-2V promoter). Our results demonstrate the appearance of eGFP-expressing cells during the differentiation of the hESC as embryoid bodies (EBs) that can be identified and sorted using FACS (purity>95%, viability>85%). The eGFP-expressing cells were stained positively for cardiac-specific proteins (>93%), expressed cardiac-specific genes, displayed cardiac-specific action-potentials, and could form stable myocardial cell grafts following in vivo cell transplantation. The generation of these transgenic hESC lines may be used to identify and study early cardiac precursors for developmental studies, to robustly quantify the extent of cardiomyocyte differentiation, to label the cells for in vivo grafting, and to allow derivation of purified cell populations of cardiomyocytes for future myocardial cell therapy strategies.

摘要

人胚胎干细胞(hESC)是多能细胞系,能够在体外分化为包括心肌细胞在内的所有三个胚层的细胞衍生物。这些独特的细胞在心血管研究和再生医学领域的成功应用受到了阻碍,因为难以从分化细胞的混合群体中识别和选择特定的心脏祖细胞。我们报告了使用慢病毒载体生成稳定的转基因hESC系,以及在心脏特异性启动子(人类肌球蛋白轻链-2V启动子)的转录控制下表达报告基因(eGFP)的单细胞克隆。我们的结果表明,在hESC分化为胚状体(EB)的过程中出现了表达eGFP的细胞,这些细胞可以使用荧光激活细胞分选术(FACS)进行识别和分选(纯度>95%,活力>85%)。表达eGFP的细胞对心脏特异性蛋白呈阳性染色(>93%),表达心脏特异性基因,显示心脏特异性动作电位,并且在体内细胞移植后能够形成稳定的心肌细胞移植体。这些转基因hESC系的产生可用于识别和研究发育研究中的早期心脏前体细胞,以可靠地量化心肌细胞分化的程度,为体内移植标记细胞,并允许获得纯化的心肌细胞群体,用于未来的心肌细胞治疗策略。

相似文献

1
Identification and selection of cardiomyocytes during human embryonic stem cell differentiation.人胚胎干细胞分化过程中心肌细胞的鉴定与筛选。
FASEB J. 2007 Aug;21(10):2551-63. doi: 10.1096/fj.05-5711com. Epub 2007 Apr 13.
2
Connexin 40 promoter-based enrichment of embryonic stem cell-derived cardiovascular progenitor cells.基于连接蛋白40启动子的胚胎干细胞来源的心血管祖细胞富集
Cells Tissues Organs. 2008;188(1-2):62-9. doi: 10.1159/000119408. Epub 2008 Feb 29.
3
Selection of ventricular-like cardiomyocytes from ES cells in vitro.体外从胚胎干细胞中筛选心室样心肌细胞。
FASEB J. 2000 Dec;14(15):2540-8. doi: 10.1096/fj.00-0002com.
4
Generation of high-level stable transgene expressing human embryonic stem cell lines using Chinese hamster elongation factor-1 alpha promoter system.利用中国仓鼠延伸因子-1α启动子系统生成高水平稳定表达转基因的人胚胎干细胞系。
Stem Cells Dev. 2008 Aug;17(4):825-36. doi: 10.1089/scd.2007.0233.
5
Xenogeneic embryonic stem cell-derived cardiomyocyte transplantation.异种胚胎干细胞来源的心肌细胞移植。
Transplant Proc. 2004 Oct;36(8):2507-8. doi: 10.1016/j.transproceed.2004.06.031.
6
Applying a "double-feature" promoter to identify cardiomyocytes differentiated from human embryonic stem cells following transposon-based gene delivery.应用“双特征”启动子来鉴定在基于转座子的基因递送后从人胚胎干细胞分化而来的心肌细胞。
Stem Cells. 2009 May;27(5):1077-87. doi: 10.1002/stem.45.
7
TERT over-expression affects the growth of myocardial tissue derived from mouse embryonic stem cells.TERT 过表达影响源自小鼠胚胎干细胞的心肌组织的生长。
Differentiation. 2010 Jan;79(1):1-8. doi: 10.1016/j.diff.2009.09.003. Epub 2009 Oct 6.
8
Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes.使用人胚胎干细胞衍生心肌细胞的心肌再生策略。
J Control Release. 2006 Nov 28;116(2):211-8. doi: 10.1016/j.jconrel.2006.06.027. Epub 2006 Jun 29.
9
Use of long-term cultured embryoid bodies may enhance cardiomyocyte differentiation by BMP2.长期培养的胚状体的使用可能会增强骨形态发生蛋白2(BMP2)诱导的心肌细胞分化。
Yonsei Med J. 2008 Oct 31;49(5):819-27. doi: 10.3349/ymj.2008.49.5.819.
10
Creation of engineered human embryonic stem cell lines using phiC31 integrase.使用φC31整合酶创建工程化人类胚胎干细胞系。
Stem Cells. 2008 Jan;26(1):119-26. doi: 10.1634/stemcells.2007-0283. Epub 2007 Oct 25.

引用本文的文献

1
ROMO1 overexpression protects the mitochondrial cysteinome from oxidations in aging.ROMO1过表达可保护线粒体蛋白质组在衰老过程中免受氧化。
Nat Commun. 2025 Jun 3;16(1):5133. doi: 10.1038/s41467-025-60503-z.
2
Opportunities and challenges in cardiac tissue engineering from an analysis of two decades of advances.从二十年的进展分析看心脏组织工程的机遇与挑战。
Nat Biomed Eng. 2022 Apr;6(4):327-338. doi: 10.1038/s41551-022-00885-3. Epub 2022 Apr 27.
3
Advances in Manufacturing Cardiomyocytes from Human Pluripotent Stem Cells.人多能干细胞来源心肌细胞的制造进展。
Annu Rev Chem Biomol Eng. 2022 Jun 10;13:255-278. doi: 10.1146/annurev-chembioeng-092120-033922. Epub 2022 Mar 23.
4
Myosin light chain 2 marks differentiating ventricular cardiomyocytes derived from human embryonic stem cells.肌球蛋白轻链 2 标记来自人胚胎干细胞的分化心室心肌细胞。
Pflugers Arch. 2021 Jul;473(7):991-1007. doi: 10.1007/s00424-021-02578-3. Epub 2021 May 24.
5
Regulatory Light Chains in Cardiac Development and Disease.心脏发育和疾病中的调节轻链。
Int J Mol Sci. 2021 Apr 21;22(9):4351. doi: 10.3390/ijms22094351.
6
Stem cell therapy of myocardial infarction: a promising opportunity in bioengineering.心肌梗死的干细胞治疗:生物工程领域一个充满前景的机遇。
Adv Ther (Weinh). 2020 Mar;3(3). doi: 10.1002/adtp.201900182. Epub 2020 Feb 3.
7
Fluorescent PSC-Derived Cardiomyocyte Reporter Lines: Generation Approaches and Their Applications in Cardiovascular Medicine.荧光PSC衍生心肌细胞报告系:生成方法及其在心血管医学中的应用
Biology (Basel). 2020 Nov 16;9(11):402. doi: 10.3390/biology9110402.
8
Optimizing the Use of iPSC-CMs for Cardiac Regeneration in Animal Models.优化诱导多能干细胞来源的心肌细胞在动物模型中用于心脏再生的应用
Animals (Basel). 2020 Sep 2;10(9):1561. doi: 10.3390/ani10091561.
9
Multicellular Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation.心律失常的多细胞模型:聚焦心房颤动
Front Cardiovasc Med. 2020 Mar 31;7:43. doi: 10.3389/fcvm.2020.00043. eCollection 2020.
10
Mending a broken heart: current strategies and limitations of cell-based therapy.修复破碎的心:基于细胞的治疗的当前策略和局限性。
Stem Cell Res Ther. 2020 Mar 26;11(1):138. doi: 10.1186/s13287-020-01648-0.